期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

生物标志物在预测轻度认知损害转归中的作用 被引量：5

下载PDF
导出
摘要 阿尔茨海默病(AD)的最新诊断标准于2011年发布,与旧版相比,它具有两大亮点:1它提出AD分为3个阶段:痴呆阶段、AD源性轻度认知损害(MCI)阶段、临床前阶段。其中,AD源性MCI患者以记忆受损为主要特征,是AD型痴呆的高危群体。2它提出联合生物学标志物的研究用标准,以增加诊断的准确性和特异性〔1〕。目前,利用生物标志物识别易转化为AD的MCI个体成为一大研究热点。
作者 毛睿智 蒋正言
机构地区 浙江大学医学院附属第二医院精神科 浙江大学医学院附属第二医院国际保健中心
出处 《中国老年学杂志》 CAS CSCD 北大核心 2015年第14期4076-4078,共3页 Chinese Journal of Gerontology
基金 浙江省中医药科学研究基金计划(2011ZA059)
关键词 生物标志物 预测 轻度认知损害 转归
分类号 R749.16 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献12

  • 1S.M. Landau,D. Harvey,C.M. Madison,E.M. Reiman,N.L. Foster,P.S. Aisen,R.C. Petersen,L.M. Shaw,J.Q. Trojanowski,C.R. Jack,M.W. Weiner,W.J. Jagust.Comparing predictors of conversion and decline in mild cognitive impairment[J]. Neurology . 2010 (3)
  • 2Clifford R. Jack,Heather J. Wiste,Prashanthi Vemuri,Stephen D. Weigand,Matthew L. Senjem,Guang Zeng,Matt A. Bernstein,Jeffrey L. Gunter,Vernon S. Pankratz,Paul S. Aisen,Michael W. Weiner,Ronald C. Petersen,Leslie M. Shaw,John Q. Trojanowski.Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimers disease. Brain . 2010
  • 3Guy M. McKhann,David S. Knopman,Howard Chertkow,Bradley T. Hyman,Clifford R. Jack,Claudia H. Kawas,William E. Klunk,Walter J. Koroshetz,Jennifer J. Manly,Richard Mayeux,Richard C. Mohs,John C. Morris,Martin N. Rossor,Philip Scheltens,Maria C. Carrillo,Bill Thies,Sandra Weintraub,Creighton H. Phelps.The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease[J]. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association . 2011 (3)
  • 4Prasad, Kalpana,Wiryasaputra, Lynn,Ng, Amanda,Kandiah, Nagaendran.White Matter Disease Independently Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease in a Clinic Cohort[J]. EN . 2011 (6)
  • 5Clifford R Jack,David S Knopman,William J Jagust,Leslie M Shaw,Paul S Aisen,Michael W Weiner,Ronald C Petersen,John Q Trojanowski.Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade[J]. Lancet Neurology . 2010 (1)
  • 6Thompson P M,Apostolova L G.Computational anatomical methods as applied to ageing and dementia. British Journal of Radiology . 2008
  • 7Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study[J]. Neurology . 2009 (10)
  • 8Stephen D. Weigand,Prashanthi Vemuri,Heather J. Wiste,Matthew L. Senjem,Vernon S. Pankratz,Paul S. Aisen,Michael W. Weiner,Ronald C. Petersen,Leslie M. Shaw,John Q. Trojanowski,David S. Knopman,Clifford R. Jack.Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid[J]. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association . 2011 (2)
  • 9Kewei Chen,Napatkamon Ayutyanont,Jessica B.S. Langbaum,Adam S. Fleisher,Cole Reschke,Wendy Lee,Xiaofen Liu,Dan Bandy,Gene E. Alexander,Paul M. Thompson,Leslie Shaw,John Q. Trojanowski,Clifford R. Jack,Susan M. Landau,Norman L. Foster,Danielle J. Harvey,Michael W. Weiner,Robert A. Koeppe,William J. Jagust,Eric M. Reiman.Characterizing Alzheimer’s disease using a hypometabolic convergence index[J]. Neuroimage . 2011 (1)
  • 10Brian T. Gold,Nathan F. Johnson,David K. Powell,Charles D. Smith.White matter integrity and vulnerability to Alzheimer’s disease: Preliminary findings and future directions[J]. BBA - Molecular Basis of Disease . 2011 (3)

二级参考文献34

  • 1Petersen RC,Stevens JC,Ganguli M,et al.Practice parameter:early detection of dementia:mild cognitive impairment (an evidence-based review).Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2001,56:1133-1142.
  • 2Smith CD.Neuroimaging through the course of Alzheimer's disease.J Alzheimers Dis,2010,19:273-290.
  • 3Attwell D,Iadecola C.The neural basis of functional brain imaging signals.Trends Neurosci,2002,25:621-625.
  • 4Mistur R,Mosconi L,Santi SD,et al.Current Challenges for the Early Detection of Alzheimer's Disease:Brain Imaging and CSF Studies.J Clin Neurol,2009,5:153-166.
  • 5Yuan Y,Gu ZX,Wei WS.Fluorodeoxyglucose-positron-emission tomography,single-photon emission tomography,and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment:a meta-analysis.AJNR Am J Neuroradiol,2009,30:404-410.
  • 6Pagani M,Dessi B,Morbelli S,et al.MCI patients declining and not-declining at mid-term follow-up:FDG-PET findings.Curr Alzheimer Res,2010,7:287-294.
  • 7Chetelat G,Eustache F,Viader F,et al.FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.Neurocase,2005,11:14-25.
  • 8Morbelli S,Piccardo A,Villavecchia G,et al.Mapping brain morphological and functional conversion patterns in amnestic MCI:a voxel-based MRI and FDG-PET study.Eur J Nucl Med Mol Imaging,2010,37:36-45.
  • 9Hunt A,Sch(o)nknecht P,Henze M,et al.Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.Psychiatry Res,2007,155:147-154.
  • 10Nobili F,Salmaso D,Morbelli S,et al.Principal component analysis of FDG PET in amnestic MCI.Eur J Nucl Med Mol Imaging,2008,35:2191-2202.

共引文献4

同被引文献44

引证文献5

二级引证文献35

中国老年学杂志
2015年 第14期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部